1. From the Clinical Center for Minimally Invasive Urologic Cancer Treatment, Department of Urology, University of Texas Southwestern Medical Center, Dallas (DBJ, DMW, LJ, MSP, JAC) and Human Performance Institute, University of Texas at Arlington, Arlington (GVK), Texas, and Department of Urology, Emory University School of Medicine (KO), Atlanta, Georgia